Primary prostate urothelial carcinoma

Summary

Primary prostate urothelial carcinoma (MONDO:0002834) is a cancer and 1 clinical trial. A subtype of prostate carcinoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	primary prostate urothelial carcinoma
Mondo ID	MONDO:0002834
DOID	DOID:4011
NCIT	C39898
UMLS	C1514430
MedGen	271382
GARD	0023261
Anatomy (UBERON)	UBERON:0002367
Is cancer (heuristic)	yes

Also known as: primary prostate urothelial cancer · primary prostate urothelial carcinoma · prostate gland transitional cell carcinoma · prostate transitional cell carcinoma · prostate urothelial carcinoma · transitional cell carcinoma of prostate · transitional cell carcinoma of the prostate

Data availability: 1 cell line.

Disease family

This is a subtype of prostate carcinoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › carcinoma › prostate carcinoma › primary prostate urothelial carcinoma

Related subtypes (8): prostate squamous cell carcinoma, metastatic prostate carcinoma, prostate adenocarcinoma, grade III prostatic intraepithelial neoplasia, prostate small cell carcinoma, familial prostate carcinoma, hormone-resistant prostate carcinoma, castration-resistant prostate carcinoma

Subtypes (1): prostatic urethra urothelial carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06380062	Not specified	COMPLETED	Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia